The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

CGEM FINANCIAL STATEMENTS

Cullinan Oncology LLC — balance sheet, income statement and cash flow trends

CGEMCullinan Oncology LLC

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M-100 M0100 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-158 K $ · -Infinity%Operating Income-221.8 M $ · -Infinity%Pre-tax Income-204.7 M $ · -Infinity%Net Income to Owners-204.7 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $—
Gross Profit-158 K $—
Operating Income-221.8 M $—
EBITDA-204.4 M $—
Net Income to Owners-204.7 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets363.8 M
  • Equity321.8 M $88%
  • Current Liabilities40.6 M $11%
  • Long-term Liabilities1.4 M $0%

Key Figures

YoY change
Total Assets363.8 M $-30.1%
Total Liabilities42 M $+49.1%
Total Equity321.8 M $-34.6%
Cash & ST Investments334.5 M $+26.0%
Total Debt2.1 M $+36.3%
Net Debt-76.6 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-200 M-100 M0-205.3 M $Operating195.3 M $Investing2.6 M $Financing-7.4 M $Net Change

Key Figures

YoY change
Operating Cash Flow-205.3 M $—
Capital Expenditures36.9 M $—
Free Cash Flow-205.3 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CGEM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.